| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260167.1 |
Tanespimycin |
Brain lower grade glioma |
0.009810024 |
Resistant |
| ENSG00000260167.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.004852542 |
Resistant |
| ENSG00000260167.1 |
Tanespimycin |
Thyroid carcinoma |
0.039569207 |
Resistant |
